دورية أكاديمية
Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance.
العنوان: | Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance. |
---|---|
المؤلفون: | Akindigh TM; Infectious Diseases Unit, Jos University Teaching Hospital, Jos, Nigeria., Joseph AO; Infectious Diseases Unit, Jos University Teaching Hospital, Jos, Nigeria., Robert CO; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Okojokwu OJ; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Okechalu JN; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Anejo-Okopi JA; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria. |
المصدر: | African journal of laboratory medicine [Afr J Lab Med] 2019 Jun 27; Vol. 8 (1), pp. 622. Date of Electronic Publication: 2019 Jun 27 (Print Publication: 2019). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: AOSIS OpenJournals Country of Publication: South Africa NLM ID: 101603205 Publication Model: eCollection Cited Medium: Print ISSN: 2225-2002 (Print) Linking ISSN: 22252002 NLM ISO Abbreviation: Afr J Lab Med Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Durbanville, South Africa : AOSIS OpenJournals, [2012]- |
مستخلص: | We report the seroprevalence of hepatitis B surface antigen among HIV-positive patients at a clinic in North-Central Nigeria. Screening for hepatitis B virus was based on serological markers. Alanine aminotransferase levels and CD4+ T-lymphocyte counts were compared between patients. The study showed that 9.2% were positive for hepatitis B surface antigen with significant differences between alanine aminotransferase levels of patients with and without hepatitis B virus. We recommend a national surveillance system to monitor control efforts. Competing Interests: The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article. |
References: | Virol J. 2005 Sep 28;2:82. (PMID: 16191199) Afr Health Sci. 2012 Sep;12(3):312-7. (PMID: 23382745) JAMA. 2000 Jan 5;283(1):74-80. (PMID: 10632283) Lancet Infect Dis. 2007 Jun;7(6):402-9. (PMID: 17521593) J Hepatol. 2010 Apr;52(4):508-13. (PMID: 20206400) Niger J Clin Pract. 2015 Mar-Apr;18(2):163-72. (PMID: 25665986) J Infect Dev Ctries. 2009 Jun 01;3(5):369-75. (PMID: 19759507) J Hepatol. 1997 Jul;27(1):18-24. (PMID: 9252068) J Hepatol. 2006;44(1 Suppl):S65-70. (PMID: 16338021) AIDS. 2007 Jun 19;21(10):1301-8. (PMID: 17545706) J Med Virol. 2016 Mar;88(3):455-60. (PMID: 26255632) Ann Hepatol. 2008 Apr-Jun;7(2):152-6. (PMID: 18626434) Saudi J Gastroenterol. 2012 Mar-Apr;18(2):81-6. (PMID: 22421711) Pan Afr Med J. 2016 Mar 25;23:128. (PMID: 27279955) Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16. (PMID: 15508102) J Hepatol. 2010 Apr;52(4):514-22. (PMID: 20207438) J Hepatol. 2006;44(1 Suppl):S6-9. (PMID: 16352363) Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8. (PMID: 18054753) Vaccine. 2012 Mar 9;30(12):2212-9. (PMID: 22273662) Gut. 1996;38 Suppl 2:S5-12. (PMID: 8786055) |
فهرسة مساهمة: | Keywords: Alanine aminotransferase; Antiretroviral therapy; CD4+ T-lymphocytes; HIV; Serological markers; hepatitis B virus |
تواريخ الأحداث: | Date Created: 20190717 Latest Revision: 20240718 |
رمز التحديث: | 20240718 |
مُعرف محوري في PubMed: | PMC6620520 |
DOI: | 10.4102/ajlm.v8i1.622 |
PMID: | 31309044 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2225-2002 |
---|---|
DOI: | 10.4102/ajlm.v8i1.622 |